ATE371462T1 - Verbesserung der herstellung von endogenen gonadotropin - Google Patents
Verbesserung der herstellung von endogenen gonadotropinInfo
- Publication number
- ATE371462T1 ATE371462T1 AT03706050T AT03706050T ATE371462T1 AT E371462 T1 ATE371462 T1 AT E371462T1 AT 03706050 T AT03706050 T AT 03706050T AT 03706050 T AT03706050 T AT 03706050T AT E371462 T1 ATE371462 T1 AT E371462T1
- Authority
- AT
- Austria
- Prior art keywords
- gonadotropin
- endogene
- improved production
- administering
- patient
- Prior art date
Links
- 102000006771 Gonadotropins Human genes 0.000 title abstract 2
- 108010086677 Gonadotropins Proteins 0.000 title abstract 2
- 239000002622 gonadotropin Substances 0.000 title abstract 2
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 abstract 1
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/063,197 US20030186892A1 (en) | 2002-03-28 | 2002-03-28 | Enhancement of endogenous gonadotropin production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE371462T1 true ATE371462T1 (de) | 2007-09-15 |
Family
ID=28452200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03706050T ATE371462T1 (de) | 2002-03-28 | 2003-01-31 | Verbesserung der herstellung von endogenen gonadotropin |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030186892A1 (de) |
| EP (1) | EP1490091B1 (de) |
| JP (1) | JP2006502969A (de) |
| AT (1) | ATE371462T1 (de) |
| CA (1) | CA2480626A1 (de) |
| DE (1) | DE60315964T2 (de) |
| ES (1) | ES2292938T3 (de) |
| MX (1) | MXPA04009455A (de) |
| WO (1) | WO2003082319A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
| US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| CA2604943C (en) | 2005-04-15 | 2013-09-17 | Clarus Therapeutics, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| EP2461818B1 (de) | 2009-08-03 | 2018-10-17 | Incube Labs, Llc | Schluckbare kapsel und verfahren zur stimulation der inkretinproduktion im darmtrakt |
| US8759284B2 (en) | 2009-12-24 | 2014-06-24 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| US9149617B2 (en) | 2010-12-23 | 2015-10-06 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
| US8809271B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US8764733B2 (en) | 2010-12-23 | 2014-07-01 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| US20130288968A1 (en) * | 2012-04-30 | 2013-10-31 | Sun Pharmaceutical Industries Ltd. | Leuprolide injection |
| US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| WO2020018974A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |
| US11564933B2 (en) | 2019-04-12 | 2023-01-31 | Tolmar, Inc. | Methods of treating testosterone deficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5538948A (en) * | 1987-01-30 | 1996-07-23 | Novo Nordisk A/S | Method for treating infertility comprising administering GnRH analog, gonadotrophins, and growth hormone |
| DK272789D0 (da) * | 1989-06-02 | 1989-06-02 | Novo Nordisk As | Fremgangsmaade og praeparat til behandling af infertilitet |
| DE4305225A1 (de) * | 1993-02-19 | 1994-08-25 | Asta Medica Ag | Neues Herstellverfahren für Cetrorelix Lyophilisat |
| JP3098401B2 (ja) * | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
| EP0788799A3 (de) * | 1996-02-07 | 1998-10-21 | ASTA Medica Aktiengesellschaft | LHRH-Antagoniste für Behandlung von Fruchtbarkeitsstörungen |
| NZ334236A (en) * | 1996-08-30 | 2000-06-23 | Peptech Ltd | Composition comprising GnRH, lecithin and stearin |
| CZ301912B6 (cs) * | 1998-04-23 | 2010-07-28 | Zentaris Ivf Gmbh | Lécivo na lécení neplodnosti nitrodeložní inseminací |
| US6265393B1 (en) * | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
| WO2000027193A1 (en) * | 1998-11-12 | 2000-05-18 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a gonadotropin releasing hormone analog |
-
2002
- 2002-03-28 US US10/063,197 patent/US20030186892A1/en not_active Abandoned
-
2003
- 2003-01-31 EP EP03706050A patent/EP1490091B1/de not_active Expired - Lifetime
- 2003-01-31 ES ES03706050T patent/ES2292938T3/es not_active Expired - Lifetime
- 2003-01-31 DE DE60315964T patent/DE60315964T2/de not_active Expired - Fee Related
- 2003-01-31 MX MXPA04009455A patent/MXPA04009455A/es unknown
- 2003-01-31 AT AT03706050T patent/ATE371462T1/de not_active IP Right Cessation
- 2003-01-31 JP JP2003579856A patent/JP2006502969A/ja active Pending
- 2003-01-31 CA CA002480626A patent/CA2480626A1/en not_active Abandoned
- 2003-01-31 WO PCT/US2003/003131 patent/WO2003082319A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2480626A1 (en) | 2003-10-09 |
| US20030186892A1 (en) | 2003-10-02 |
| EP1490091B1 (de) | 2007-08-29 |
| DE60315964T2 (de) | 2008-05-15 |
| DE60315964D1 (de) | 2007-10-11 |
| MXPA04009455A (es) | 2005-01-25 |
| JP2006502969A (ja) | 2006-01-26 |
| WO2003082319A1 (en) | 2003-10-09 |
| ES2292938T3 (es) | 2008-03-16 |
| EP1490091A1 (de) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE371462T1 (de) | Verbesserung der herstellung von endogenen gonadotropin | |
| ATE362770T1 (de) | Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen | |
| EE05302B1 (et) | 4-fluoro-N-(indaan-2-l)bensamiidi kasutamine ja protsess ravimi valmistamiseks | |
| DE60115842D1 (de) | Ventilanordnung | |
| EA200101089A1 (ru) | Новый способ лечения | |
| SE0301886D0 (sv) | New use V | |
| ATE234090T1 (de) | Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz | |
| SE0301882D0 (sv) | New use I | |
| AR023130A1 (es) | Composiciones para promover el crecimiento | |
| PL338705A1 (en) | Application of gaba analogues in preventing and treating gastrointestinal diseases | |
| CR10167A (es) | "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor" | |
| MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| ATE294188T1 (de) | Peptidische inhibitoren der lfa-1/icam-1 interaktion | |
| MY139203A (en) | Pharmaceutical composition | |
| ATE461707T1 (de) | Pharmazeutische verbindung und methoden zur behandlungen von menschliche karzinome mittels arginin entzug | |
| DE60115433D1 (de) | Verfahren zur behandlung von chronischen geschwüren | |
| EP1543158A4 (de) | Regulierte aptamer-therapeutika | |
| ATE454155T1 (de) | Verwendung von drospirenon zur behandlung von hypertension | |
| DE60140960D1 (de) | Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis | |
| DE60334556D1 (de) | Chorionic gonadotropin zur Behandlung des chronischen Schmerzsyndroms des Beckens | |
| DE60030107D1 (de) | Vitamin-d derivate zur behandlung des systemischen lupus erythematodes | |
| DE60334830D1 (de) | Furin-hemmer zur behandlung von fibrose und narbenbildung | |
| UY26648A1 (es) | Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada | |
| SE0301883D0 (sv) | New use II | |
| CY1105564T1 (el) | Θεραπεια συνδυασμου για καρκινο |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |